In this study, we explored C8A mRNA as a predictive biomarker in the HERA DASL cohort, as a prognostic marker of outcome in gastric cancer, and as a possible indicator of a specific HER2 subtype. This evidence concerns the gene ERBB2 and gastric cancer.